Literature DB >> 28796391

Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation.

Giovanni Varotti1, Ferdinando Dodi2, Alessia Terulla1, Gregorio Santori3, Gabriele Mariottini1, Massimo Bertocchi1, Anna Marchese4, Iris Fontana1.   

Abstract

BACKGROUND: Carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in solid organ transplant patients are progressively increasing and are associated with worse outcomes, although potential risk factors and therapeutic strategies are still not well defined.
METHODS: We conducted a retrospective matched-pair analysis in which we compared 26 recipients CR-KP-positive after kidney transplantation (KT) with 52 CR-KP-negative patients transplanted in the same period, during a CR-KP outbreak that occurred in our hospital. Twenty-one patients (80%) received a combined antibiotic treatment. At the end of the follow-up, of the 26 CR-KP infected patients, 11 (42.3%) experienced at least one episode of re-infection, 9 (34.6%) remained colonized, and 6 (23.0%) had a symptomatic infection. Two of the 11 patients with re-infection died, while 9 were colonized at the end of the study.
RESULTS: A significantly better patient (P = .043) and graft (P < .001) survival was observed in CR-KP-negative patients. Univariate analysis identified the following variables as potential risk factors associated with CR-KP infection after KT: lower body mass index (P = .020); higher creatinine levels at post-transplant days 7 (P = .009), 15 (P = .026), and 30 (P = .019); longer hospital stay (P = .007); longer cold ischemia time (P = .004); delayed graft function (P = .020); and higher Clavien-Dindo score (P = .006).
CONCLUSION: The study confirmed that a CR-KP positivity may affect the outcome of a kidney transplant population. In severe CR-KP infections with sepsis, a combined antibiotic treatment seems to be advisable.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  carbapenem-resistant Klebsiella pneumoniae; kidney transplant

Mesh:

Substances:

Year:  2017        PMID: 28796391     DOI: 10.1111/tid.12757

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  3 in total

1.  Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis.

Authors:  Wei-Min Zhu; Zhe Yuan; Hong-Yu Zhou
Journal:  Antimicrob Resist Infect Control       Date:  2020-01-31       Impact factor: 4.887

2.  Burden of carbapenem non-susceptible infections in high-risk patients: systematic literature review and meta-analysis.

Authors:  Esther E Avendano; Gowri Raman; Jeffrey Chan; Eilish McCann
Journal:  Antimicrob Resist Infect Control       Date:  2020-12-07       Impact factor: 4.887

3.  Mortality, clinical and microbiological response following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections (a meta-analysis dataset).

Authors:  Akosua A Agyeman; Phillip J Bergen; Gauri G Rao; Roger L Nation; Cornelia B Landersdorfer
Journal:  Data Brief       Date:  2019-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.